IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER
Pain, Burning
Janssen Research & Development, LLCmonoclonal_antibodyPhase 2Dormant
C
35/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 20/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Pain, Burning cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Naltrexone Hospital for Special Surgery, New York | Phase 4 | BB |
Etoricoxib Ruhr University of Bochum | Phase 2 | CCC |
Dynastat | D | |
Neurotropin National Institute of Nursing Research (NINR) | Phase 2 | NR |
Incobotulinumtoxin-A Bo Biering-Soerensen | N/A | NR |
Same molecule, other indications
IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →